Search

everythinglearnresearchcommunity

for

Search:↓

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Baricitinib may effectively treat oral lichen planus.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Combining calcipotriol and PRP is most effective for treating Alopecia Areata.

Talquetamab may cause hair loss and skin issues.

Minoxidil might help treat acne scars by reducing collagen buildup.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Non-invasive methods can effectively diagnose and manage alopecia areata.

The document concludes that identifying the cause of eyebrow and eyelash loss is key to treating it and improving quality of life.

Baricitinib is a new, effective treatment for advanced alopecia areata but is costly and has risks.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Frontal fibrosing alopecia and ulerythema ophryogenes may be related and can evolve from one to the other.

Sinsun-yukza-hwan extract promotes hair growth in mice.

Different nail disorders are treated by targeting their specific causes and using appropriate medications or protective measures.

The document concludes that alopecia has various forms, each with specific treatments, but no definitive cure for certain types like CCCA has been proven.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.